Myocardial fibrosis predicts ventricular tachyarrhythmias

Trends in Cardiovascular Medicine

Volumn 27, Issue 5, 2017, Pages 363-372

  Disertori, Marcello ^a,b   Masè, Michela ^c   Ravelli, Flavia ^c  

^a FONDAZIONE BRUNO KESSLER   (Italy)

^b SANTA CHIARA HOSPITAL   (Italy)

^c UNIVERSITY OF TRENTO   (Italy)

Author keywords

Arrhythmias; Cardiomyopathy; Fibrosis; Implantable cardioverter defibrillator; Late gadolinium enhancement; Sudden cardiac death

Indexed keywords

GADOLINIUM;

CARDIOVASCULAR MAGNETIC RESONANCE; CONGESTIVE CARDIOMYOPATHY; CONTRAST ENHANCEMENT; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE BIOPSY; HEART MUSCLE FIBROSIS; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; ISCHEMIC CARDIOMYOPATHY; NON INVASIVE PROCEDURE; NONISCHEMIC DILATED CARDIOMYOPATHY; PRIORITY JOURNAL; REVIEW; SUDDEN CARDIAC DEATH; ANIMAL; BIOPSY; CARDIAC MUSCLE; CARDIOMYOPATHY; CARDIOVERSION; COMPLICATION; DEVICES; DIAGNOSTIC IMAGING; ELECTROCARDIOGRAPHY; FIBROSIS; HEART ARRHYTHMIA; HEART RATE; HEART VENTRICLE FUNCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; RISK FACTOR; TREATMENT OUTCOME;

ANIMALS; ARRHYTHMIAS, CARDIAC; BIOPSY; CARDIOMYOPATHIES; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; FIBROSIS; HEART RATE; HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION;

EID: 85014129660     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2017.01.011     Document Type: Review

References (46)

1. Jellis, C., Martin, J., Narula, J., Marwick, T.H., Assessment of nonischemic myocardial fibrosis. J Am Coll Cardiol 56 (2010), 89–97.
2. Nguyen, T.P., Qu, Z., Weiss, J.N., Cardiac fibrosis and arrhythmogenesis: the road to repair is paved with perils. J Mol Cell Cardiol 70 (2014), 83–91.
3. Morita, N., Mandel, W.J., Kobayashi, Y., Karagueuzian, H.S., Cardiac fibrosis as a determinant of ventricular tachyarrhythmias. J Arrhythm 30 (2014), 389–394.
4. van der Bijl, P., Delgado, V., Bax, J.J., Noninvasive imaging markers associated with sudden cardiac death. Trends Cardiovasc Med 26 (2016), 348–360.
5. Disertori, M., Rigoni, M., Pace, N., Casolo, G., Masè, M., Gonzini, L., et al. Myocardial fibrosis assessment by LGE is a powerful predictor of ventricular tachyarrhythmias in ischemic and nonischemic LV dysfunction. A meta-Anal J Am Coll Cardiol Img 9 (2016), 1046–1055.
6. de Jong, S., van Veen, T.A., van Rijen, H.V., de Bakker, J.M., Fibrosis and cardiac arrhythmias. J Cardiovasc Pharmacol 57 (2011), 630–638.
7. Arenal, A., Hernández, J., Pérez-David, E., Rubio-Guivernau, J.L., Ledesma-Carbayo, M.J., Fernández-Avilés, F., Do the spatial characteristics of myocardial scar tissue determine the risk of ventricular arrhythmias?. Cardiovasc Res 94 (2012), 324–332.
8. Trayanova, N.A., Boyle, P.M., Arevalo, H.J., Zahid, S., Exploring susceptibility to atrial and ventricular arrhythmias resulting from remodeling of the passive electrical properties in the heart: a simulation approach. Front Physiol, 5, 2014, 435.
9. Arevalo, H.J., Vadakkumpadan, F., Guallar, E., Jebb, A., Malamas, P., Wu, K.C., et al. Arrhythmia risk stratification of patients after myocardial infarction using personalized heart models. Nat Commun, 7, 2016, 11437.
10. Rog-Zielinska, E.A., Norris, R.A., Kohl, P., Markwald, R., The living scar–cardiac fibroblasts and the injured heart. Trends Mol Med 22 (2016), 99–114.
11. Das, M.K., Khan, B., Jacob, S., Kumar, A., Mahenthiran, J., Significance of a fragmented QRS complex versus a Q wave in patients with coronary artery disease. Circulation 113 (2006), 2495–2501.
12. Roes, S.D., Mollema, S.A., Lamb, H.J., van der Wall, E.E., de Roos, A., Bax, J.J., Validation of echocardiographic two-dimensional speckle tracking longitudinal strain imaging for viability assessment in patients with chronic ischemic left ventricular dysfunction and comparison with contrast-enhanced magnetic resonance imaging. Am J Cardiol 104 (2009), 312–317.
13. Flevari, P., Theodorakis, G., Leftheriotis, D., Kroupis, C., Kolokathis, f., Dima, K., et al. Serum markers of deranged myocardial collagen turnover: their relation to malignant ventricular arrhythmias in cardioverter-defibrillator recipients with heart failure. Am Heart J 164 (2012), 530–537.
14. Lopez, B., Gonzales, A., Ravassa, S., Beaumont, J., Moreno, M.U., san José, G., et al. Circulating biomarkers of myocardial fibrosis. The need for a reappraisal. J Am Coll Cardiol 65 (2015), 2449–2456.
15. Iles, L.M., Ellims, A.H., Llewellyn, H., Hare, J.L., Kaye, D.M., McLean, C.A., et al. Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis. Eur Heart J Cardiovasc Imaging 16 (2015), 14–22.
16. Everett, R.J., Stirrat, C.G., Semple, S.I., Newby, D.E., Dweck, M.R., Mirsadraee, S., Assessment of myocardial fibrosis with T1 mapping MRI. Clin Radiol 71 (2016), 768–778.
17. Roes, S.D., Borleffs, C.J., van der Geest, R.J., Westenberg, J.J., Marsan, N.A., Kaandorp, T.A., et al. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmias in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator. Circ Cardiovasc Imaging 2 (2009), 183–190.
18. Demirel, F., Adiyaman, A., Timmer, J.R., Dambrink, J.H., Kok, M., Boeve, W.J., et al. Myocardial scar characteristics based on cardiac magnetic resonance imaging is associated with ventricular tachyarrhythmia in patients with ischemic cardiomyopathy. Int J Cardiol 177 (2014), 392–399.
19. Scott, P.A., Rosengarten, J.A., Curzen, N.P., Morgan, J.M., Late gadolinium enhancement cardiac magnetic resonance imaging for the prediction of ventricular tachyarrhythmic events: a meta-analysis. Eur J Heart Fail 15 (2013), 1019–1027.
20. Gulati, A., Jabbour, A., Ismail, T.F., Guha, K., Khwaja, J., Raza, S., et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA 309 (2013), 896–908.
21. Kuruvilla, S., Adenaw, N., Katwal, A.B., Lipinski, M.J., Kramer, C.M., Salerno, M., Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis. Circ Cardiovasc Imaging 7 (2014), 250–258.
22. Di Marco, A., Anguerra, I., Schmitt, M., Klem, I., Neilan, T., White, J.A., et al. Late gadolinium enhancement and the risk of ventricular arrhythmias or sudden death in dilated cardiomyopathy: systematic review and meta-analysis. J Am Coll Cardiol HF 5 (2017), 28–38.
23. Piers, S.R., Everaerts, K., van der Geest, R.J., Hazebroek, M.R., Siebelink, H.-M., Pison, L., et al. Myocardial scar predicts monomorphic ventricular tachycardia but not polymorphic ventricular tachycardia or ventricular fibrillation in nonischemic dilated cardiomyopathy. Heart Rhythm 2 (2015), 2106–2114.
24. Green, J.J., Berger, J.S., Kramer, C.M., Salerno, M., Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy. J Am Coll Cardiol Img 5 (2012), 370–377.
25. Weng, Z., Yao, J., Chan, R.H., He, J., Yang, X., Zhou, Y., et al. Prognostic value of LGE-CMR in HCM. A meta-analysis. J Am Coll Cardiol Img 9 (2016), 1392–1402.
26. Chan, R.H., Maron, B.J., Olivotto, I., Pencina, M.J., Assenza, G.E., Haas, T., et al. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. Circulation 130 (2014), 484–495.
27. Das, M.K., Zipes, D.P., Fragmented QRS: a predictor of mortality and sudden cardiac death. Heart Rhythm 6 (2009), S8–S14.
28. Rosengarten, J.A., Scott, P.A., Morgan, J.M., Fragmented QRS for prediction of sudden cardiac death: a meta-analysis. Europace 17 (2015), 969–977.
29. Ng, A.C., Bertini, M., Borleffs, C.J., Delgado, V., Boersma, E., Piers, S.R., et al. Predictors of death and occurrence of appropriate implantable defibrillator therapies in patients with ischemic cardiomyopathy. Am J Cardiol 106 (2010), 1566–1573.
30. Kosiuk, J., Dinov, B., Bollmann, A., Koutalas, E., Mussigbrodt, A., Sommer, P., et al. Association between ventricular arrhythmias and myocardial mechanical dispersion assessed by strain analysis in patients with nonischemic cardiomyopathy. Clin Res Cardiol 104 (2015), 1072–1077.
31. Haland, T.F., Almaas, V.M., Hasselberg, N.E., Saberniak, J., Leren, I.S., Hopp, E., et al. Strain echocardiography is related to fibrosis and ventricular arrhythmias in hypertrophic cardiomyopathy. Eur Heart J Cardiovasc Imaging 17 (2016), 613–621.
32. Hasselberg, N.E., Haugaa, K.H., Bernard, A., Ribe, M.P., Kongsgaard, E., Donald, E., et al. Left ventricular markers of mortality and ventricular arrhythmias in heart failure patients with cardiac resynchronization therapy. Eur Heart J Cardiovasc Imaging 17 (2016), 343–350.
33. Biering-Sorensen, T., Knappe, D., Pouleur, A.-C., Clagget, B., Wang, P.J., Moss, A.J., et al. Regional longitudinal deformation improves prediction of ventricular tachyarrhythmias in patients with heart failure with reduced ejection fraction. A MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy). Circ Cardiovasc Imaging, 10(1), 2017 [pii e005096].
34. Kanoupakis, E.M., Manios, E.G., Kallergis, E.M., Mavrakis, H.E., Goudis, C.A., Saloustros, I.G., et al. Serum markers of collagen turnover predict future shocks in implantable cardioverter-defibrillator recipients with dilated cardiomyopathy on optimal treatment. J Am Coll Cardiol 55 (2010), 2753–2759.
35. Priori, S.G., Blomstrom-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., et al. ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 2015:36 (2015), 2793–2867.
36. van der Heijden, A.C., Borleffs, C.J., Buiten, M.S., Thijssen, J., van Rees, J.B., Cannegieter, S.C., et al. The clinical course of patients with implantable cardioverter-defibrillators: extended experience on clinical outcome, device replacements, and device-related complications. Heart Rhythm 12 (2015), 1169–1176.
37. Seegers, J., Bergau, L., Tichelbacker, T., Malik, M., Zabel, M., ICD risk stratification studies – Eu-CERT-ICD and the European perspective. J Electrocardiol 49 (2016), 831–836.
38. Wellens, H.J.J., Schwartz, P.J., Lindemans, F.W., Buxton, A.E., Goldberger, J.J., Hohnloser, S.H., et al. Risk stratification for sudden cardiac death: current status and challenges for the future. Eur Heart J 35 (2014), 1642–1651.
39. Køber, L., Thune, J.J., Nielsen, J.C., Haarbo, J., Videbæk, L., Korup, E., et al. Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med 375 (2016), 1221–1230.
40. Disertori, M., Quintarelli, S., Mazzola, S., Favalli, V., Narula, N., Arbustini, E., The need to modify patient selection to improve the benefits of implantable cardioverter-defibrillator for primary prevention of sudden death in non-ischaemic dilated cardiomyopathy. Europace 15 (2013), 1693–1701.
41. Disertori, M., Gulizia, M.M., Casolo, G., Delise, P., Di Lenarda, A., Di Tano, G., et al. Improving the appropriateness of sudden arrhythmic death primary prevention by implantable cardioverter-defibrillator therapy in patients with low left ventricular ejection fraction. Point view J Cardiovasc Med 17 (2016), 245–255.
42. Buxton, A.E., Implantable cardioverter-defibrillator for primary prevention of sudden death. The quest to identify patients most likely to benefit. J Am Coll Cardiol 60 (2012), 1656–1658.
43. Andreu, D., Ortiz-Perez, J.T., Fernandez-Armenta, J., Guiu, E., Acosta, J., Prat-Gonzales, S., et al. 3D delayed-enhancement magnetic resonance sequences improve conducting channel delineation prior to ventricular tachycardia ablation. Europace 17 (2015), 938–945.
44. Zhang, J., Cooper, D.H., Desouza, K.A., Cuculich, P.S., Woodard, P.K., Smith, T.W., et al. Electrophysiologic scar substrate in relation to VT: noninvasive high-resolution mapping and risk assessment with ECGI. PACE 39 (2016), 781–791.
45. Disertori, M., Masè, M., Rigoni, M., Nollo, G., Ravelli, F., Heart rate turbulence is a powerful predictor of cardiac death and ventricular arrhythmias in postmyocardial infarction and heart failure patients. A systematic review and meta-analysis. Circ Arrhythm Electro, 9(12), 2016 [pii e004610].
46. Arbustini, E., Disertori, M., Narula, J., Primary prevention of sudden arrhythmic death in dilated cardiomyopathy: current guidelines and risk stratification. J Am Coll Cardiol HF 5 (2017), 39–43.